ApoB (apolipoprotein B) is a protein that sits on every particle in your blood that can build plaque in your arteries. Because each of those particles carries exactly one ApoB, an ApoB test counts them. That count gives one of the clearest single measures of how much cholesterol is pushing into your artery walls, so ApoB tracks your heart attack and stroke risk.
What is ApoB?
ApoB is the main protein on LDL, VLDL, and Lp(a) particles, with exactly one ApoB per particle. Measuring it gives you a direct count of how many potentially harmful particles are circulating in your bloodstream.
Standard cholesterol tests measure the amount of cholesterol carried inside LDL particles (LDL-C). But the amount of cholesterol per particle varies from person to person. Two people can have the same LDL-C while having very different numbers of LDL particles. The person with more particles generally has more risk, even if their LDL-C looks the same. ApoB captures that difference.
Why does ApoB matter for heart risk?
These particles get trapped in the artery wall and start plaque. The more particles you have, and the longer you have them, the more plaque builds.
Atherosclerosis, the process behind heart attacks and strokes, begins when ApoB-containing particles enter the artery wall and get stuck. Over years and decades, these trapped particles trigger inflammation and form plaques (how heart disease develops walks through the timeline).
A 2017 consensus statement from the European Atherosclerosis Society reviewed genetic studies, large cohorts, and randomized trials and concluded that LDL and related particles cause atherosclerotic heart disease. It found that lowering the number of these particles lowers risk in proportion to how much they fall and for how long.
Source
Ference BA et al. “Low-density lipoproteins cause atherosclerotic cardiovascular disease.” European Heart Journal (2017).
View paperThe lower your ApoB, the fewer particles are available to drive plaque formation.
What is a good ApoB level?
A good ApoB level depends on your risk: below 90 mg/dL for lower-risk adults, below 70 for higher risk, and below 55 for people with heart disease at very high risk. The 2026 ACC/AHA multisociety guideline on dyslipidemia sets these ApoB goals alongside its LDL goals, and leans on them most when triglycerides are elevated (150 to 499 mg/dL), when LDL cholesterol can understate how many particles you have.
- Below 90 mg/dL: primary prevention at lower risk (10-year risk under 10%) with triglycerides of 150 to 499, or diabetes without other risk factors
- Below 70 mg/dL: primary prevention at higher risk (10-year risk of 10% or more) with triglycerides of 150 to 499, diabetes with risk factors, or high triglycerides at age 40 to 75 with a risk factor
- Below 55 mg/dL: established heart disease at very high risk
Source
Blumenthal RS, Morris PB, Gaudino M, et al. “2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Journal of the American College of Cardiology (2026).
View paperSource
University of Illinois Chicago Drug Information Group “What are key updates from the 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on dyslipidemia management?.” UIC Drug Information Group FAQs (2026).
The goal list above follows the guideline's goals table as summarized by the UIC Drug Information Group. Your clinician places you in a risk group using your history, labs, and risk calculators. A cholesterol panel that looks "normal" doesn't guarantee your ApoB is at goal, especially if you have high triglycerides, diabetes, or excess weight.
How is ApoB tested?
Labs can run the ApoB blood test from the same tube as a standard lipid panel. It usually doesn't require fasting, though some labs ask for one when it's bundled with other tests. Quest, Labcorp, and most other large labs offer it, but routine panels often leave it out, so your clinician has to order it by name.
If you haven't had your ApoB measured, ask about it, especially if you have:
- A family history of early heart disease
- Metabolic syndrome, prediabetes, or type 2 diabetes
- Elevated triglycerides
- An LDL-C that seems "normal" but you want more information
Our guide on how to get an ApoB or Lp(a) test covers what to ask for, self-pay lab options, and insurance.
How do you lower ApoB?
You lower ApoB the same way you lower LDL: diet and lifestyle changes for a modest drop, and prescription medicine when the gap to your goal is bigger. Lifestyle changes like cutting saturated fat, adding soluble fiber, and losing excess weight help. For many people, particularly those with a genetic cause or a high starting level, they aren't enough to reach goal.
Prescription medicines that lower ApoB include:
- Statins, which lower LDL by 30 to 49% at moderate intensity and 50% or more at high intensity. ApoB falls a bit less, in percentage terms.
- Ezetimibe, a pill that lowers LDL by about another 25% when added to a statin
- PCSK9 inhibitors: the injections evolocumab (Repatha) and alirocumab (Praluent), the once-monthly injection Lerochol, and the daily pill Lipfendra. In a pooled analysis of evolocumab studies, ApoB fell by 46 to 52% compared with placebo.
- Inclisiran (Leqvio), a twice-yearly injection that lowered LDL by about 50% in its phase 3 trials
Source
Toth PP, Jones SR, Monsalvo ML, Elliott-Davey M, López JAG, Banach M. “Effect of Evolocumab on Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies.” Journal of the American Heart Association (2020).
View paperSource
Ray KK, Wright RS, Kallend D, et al. “Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.” New England Journal of Medicine (2020).
View paperLowering these particles hard can shrink plaque. In the GLAGOV trial, adding evolocumab to a statin shrank coronary plaque in 64% of patients, compared with 47% on a statin alone.
Source
Nicholls SJ et al. “Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.” JAMA (2016).
View paperIf statins have caused you trouble, our statin intolerance program covers how a rechallenge and non-statin options work. Our guide on how to lower ApoB puts numbers on each diet change and medicine.
Summary
ApoB is a straightforward blood test that gives a clearer picture of cardiovascular risk than LDL-C alone. If you want to understand and reduce your risk of heart disease, knowing your ApoB is a good place to start. Know your numbers.
At Preval Health, ApoB is part of every patient's initial assessment (how our testing works). Our protocols are written by a board-certified preventive cardiologist, and licensed clinicians use ApoB alongside Lp(a), LDL-C, and other markers to set your goal, then prescribe and adjust treatment until you reach it, up to and including a PCSK9 inhibitor prescription when it's needed.